MbrlCatalogueTitleDetail

Do you wish to reserve the book?
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
Journal Article

In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications

2024
Request Book From Autostore and Choose the Collection Method
Overview
Background CCR8-expressing regulatory T cells (Tregs) are selectively localized within tumors and have gained attention as potent suppressors of anti-tumor immunity. This study focused on CCR8 + Tregs and their interaction with CD8 + T cells in the tumor microenvironment of human lung cancer. We evaluated their spatial distribution impact on CD8 + T cell effector function, specifically granzyme B (GzmB) expression, and clinical outcomes. Methods A total of 81 patients with lung squamous cell carcinoma (LSCC) who underwent radical surgical resection without preoperative treatment were enrolled. Histological analyses were performed, utilizing an automated image analysis system for double-stained immunohistochemistry assays of CCR8/Foxp3 and GzmB/CD8. We investigated the association of CCR8 + Tregs and GzmB + CD8 + T cells in tumor tissues and further evaluated the prognostic impact of their distribution profiles. Results Histological evaluation using the region of interest (ROI) protocol showed that GzmB expression levels in CD8 + T cells were decreased in areas with high infiltration of CCR8 + Tregs, suggesting a suppressive effect of CCR8 + Tregs on T cell cytotoxicity in the local tumor microenvironment. Analysis of the association with clinical outcomes showed that patients with more CCR8 + Tregs and lower GzmB expression, represented by a low GzmB/CCR8 ratio, had worse progression-free survival. Conclusions Our data suggest that local CCR8 + Treg accumulation is associated with reduced CD8 + T cell cytotoxic activity and poor prognosis in LSCC patients, highlighting the biological role and clinical significance of CCR8 + Tregs in the tumor microenvironment. The GzmB/CCR8 ratio may be a useful prognostic factor for future clinical applications in LSCC.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject

Adult

/ Aged

/ Aged, 80 and over

/ Analysis

/ Antibodies

/ Antigens

/ Biomarkers, Tumor - metabolism

/ Biomedical and Life Sciences

/ Biomedicine

/ Cancer Research

/ Carcinoma, Squamous Cell - immunology

/ Carcinoma, Squamous Cell - metabolism

/ Carcinoma, Squamous Cell - pathology

/ Care and treatment

/ CC chemokine receptors

/ CCR8

/ CD8 antigen

/ CD8-Positive T-Lymphocytes - immunology

/ CD8-Positive T-Lymphocytes - metabolism

/ Cell-mediated cytotoxicity

/ Chemokines

/ Cytotoxic T cells

/ Cytotoxicity

/ Development and progression

/ Female

/ Foxp3 protein

/ Granzyme B

/ Granzymes - metabolism

/ Health Promotion and Disease Prevention

/ Humans

/ Image processing

/ Immunohistochemistry

/ Immunoregulation

/ Lung cancer

/ Lung carcinoma

/ Lung Neoplasms - immunology

/ Lung Neoplasms - metabolism

/ Lung Neoplasms - mortality

/ Lung Neoplasms - pathology

/ Lung Neoplasms - surgery

/ Lymphocytes

/ Lymphocytes T

/ Lymphocytes, Tumor-Infiltrating - immunology

/ Lymphocytes, Tumor-Infiltrating - metabolism

/ Male

/ Medical prognosis

/ Medicine/Public Health

/ Metastases

/ Middle Aged

/ Oncology

/ Patients

/ Prognosis

/ Proteins

/ Receptors, CCR8 - immunology

/ Receptors, CCR8 - metabolism

/ Regulatory T cells

/ Software

/ Spatial distribution

/ Squamous cell carcinoma

/ Statistical analysis

/ Surgical Oncology

/ T-Lymphocytes, Regulatory - immunology

/ T-Lymphocytes, Regulatory - metabolism

/ Testing

/ Tumor immunity

/ Tumor microenvironment

/ Tumor Microenvironment - immunology

/ Tumors

/ Viral antibodies